Skip to content

Comparison of proseal laryngeal mask airway and Streamlined Liner of the Pharynx Airway for gastric distension in the patients undergoing laparoscopic cholecystectomy.

Comparision of degree of gastric distension between proseal laryngeal mask airway and Streamlined Liner of the Pharynx Airway when used in the patients undergoing laparoscopic cholecystectomy.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12611001189910
Acronym
SLIPA=Streamlined Liner of the Pharynx Airway LMA-P=proseal laryngeal mask airway
Enrollment
124
Registered
2011-11-16
Start date
2011-07-13
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The Streamlined linear of the pharryngeal airway(SLIPA) is a new type of supralaryngeal airway(SLA), use of which has increased because it is inexpensive, disposable and easy to insert. Although other SLA(eg, laryngeal mask airway(LMA), laryngeal tube) have been used safely in elective laparoscopic cholecystectomy, there are few reports compare the characteristics of the SLIPA or proseal LMA(LMA-P) when used in patients undergoing laparoscopic cholecystectomy. The aim of this study is to compare the quantitative clinical performances of the SLIPA with the LMA-P with regard to the incidence of gastric insufflations when used in patients undergoing laparoscopic cholecystectomy.

Interventions

Sponsors

Hyun Kang
Lead SponsorIndividual

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used)

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

ASA 1,2 patietns undergoing elective laparoscopic cholecystectomy under general anesthesia

Exclusion criteria

Patients with a history of diabetes mellitus, gastroesophageal reflux, other neurologic or musculoskelectal disease, obesity (body mass index > 30 kg m–2) and with features or history of a difficult airway

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026